Literature DB >> 2138168

A Bayesian assessment of idiosyncratic adverse reactions to new drugs: Guillain-Barré syndrome and zimeldine.

C A Naranjo1, D Lane, M Ho-Asjoe, K L Lanctôt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2138168     DOI： 10.1002/j.1552-4604.1990.tb03459.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  5 in total

1.  Hematologic dyscrasia associated with ticlopidine therapy: evidence for causality.

Authors:  F L Paradiso-Hardy; C M Angelo; K L Lanctôt; E A Cohen
Journal:  CMAJ       Date:  2000-11-28       Impact factor: 8.262

Review 2.  Methods for causality assessment of adverse drug reactions: a systematic review.

Authors:  Taofikat B Agbabiaka; Jelena Savović; Edzard Ernst
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 3.  Recent developments in computer-assisted diagnosis of putative adverse drug reactions.

Authors:  C A Naranjo; K L Lanctôt
Journal:  Drug Saf       Date:  1991 Sep-Oct       Impact factor: 5.606

Review 4.  [Detection and evaluation of adverse drug reactions].

Authors:  P A Thürmann; K Schmitt
Journal:  Med Klin (Munich)       Date:  1998-11-15

5.  Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals.

Authors:  I Tegeder; M Levy; U Muth-Selbach; R Oelkers; F Neumann; H Dormann; T Azaz-Livshits; M Criegee-Rieck; H T Schneider; E Hahn; K Brune; G Geisslinger
Journal:  Br J Clin Pharmacol       Date:  1999-05       Impact factor: 4.335
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.